Neurodevelopmental Follow-up at 36 Months' Corrected Age of Preterm Infants Treated With Prophylactic Indomethacin | Zendy

Robert J. Couser | Zendy; Ronald Hoekstra | Zendy; Teresa Ferrara | Zendy; Gregory B. Wright | Zendy; Allison K. Cabalka | Zendy; John E. Connett | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Neurodevelopmental Follow-up at 36 Months' Corrected Age of Preterm Infants Treated With Prophylactic Indomethacin

Author(s) -

Robert J. Couser,

Ronald Hoekstra,

Teresa Ferrara,

Gregory B. Wright,

Allison K. Cabalka,

John E. Connett

Publication year - 2000

Publication title -

archives of pediatrics and adolescent medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3628

pISSN - 1072-4710

DOI - 10.1001/archpedi.154.6.598

Subject(s) - medicine , ductus arteriosus , placebo , bayley scales of infant development , pediatrics , prophylactic treatment , birth weight , randomized controlled trial , anesthesia , low birth weight , prospective cohort study , pregnancy , surgery , genetics , alternative medicine , cognition , pathology , psychiatry , biology , psychomotor learning

Previous reports have suggested that prophylactic indomethacin decreases cerebral blood flow and may play a role in the development of ischemic brain injury and developmental handicaps.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research